m+Medelevator.RU
← Поиск публикаций
Science advances · 2026

The microenvironment dictates glyco-immune surveillance via HSF1-mediated metabolism.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Tharp Kevin M, Park Sangwoo, Timblin Greg A, Richards Alicia L, Berg Jordan A, Twells Nicholas M, Riley Nicholas M, Alvarez Kyle, Lee Allen, Peltan Egan L, Shon D Judy, Stevenson Erica, Tsui Kimberly, Palomba Francesco, Lefebvre Austin E Y T, Soens Ross W, Thangaraj Jaya L, Ayad Nadia M E, Rhodenhiser Joseph A, Ten Hoeve Johanna, Healy Kevin, Digman Michelle, Dillin Andrew, Krogan Nevan J, Bertozzi Carolyn R, Kaufman Dan S, Sinha Sanju, Swaney Danielle L, Mahal Lara K, Cantor Jason R, Paszek Matthew J, Weaver Valerie M

Аннотация

Altered glucose metabolism is an auspicious feature of solid tumors, but is it an intrinsic property of tumor cells or a metabolic adaptation to the tumor microenvironment? Using normal epithelial cells cultured in a physiological culture medium under conditions that mimic the physical properties of healthy or cancerous tissues, we establish multiomics relationships between the biochemical and physical properties of the microenvironment and its impact on biosynthetic outputs of altered glucose metabolism. We find that microenvironmental properties, such as hyperglycemia, can affect the composition and thickness of the epithelial glycocalyx, in part through the activity of mechanosensitive stress responses associated with Heat Shock Factor 1 (HSF1). Because glycocalyx thickness alters immune surveillance of epithelial-origin tumor cells, we examined the relationship between the HSF1-hyperglycemia axis in human breast tumors and validate it as a druggable vulnerability to license natural killer cell lethality against cancer cells.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты